FDA authorises first tests that estimate antibodies from past COVID-19 Infection

The ADVIA Centaur COV2G and Atellica COV2G “semi-quantitative” tests do not display a precise measurement, but estimate the quantity of a patient’s antibodies produced against the COVID-19 virus. The tests do not confirm whether patients are immune or have any level of immunity.


US Food and Drug Administration